ArticleInternational journal of clinical oncology2021

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.

Yoshiaki Yamamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.